Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Kowarsch

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|December 7, 2011
PhenomiR: microRNAs in human diseases and biological processesAndreas Ruepp, Andreas Kowarsch, Fabian Theis
Plos Computational Biology|September 24, 2010
Correlated mutations: a hallmark of phenotypic amino acid substitutionsAndreas Kowarsch, Angelika Fuchs, Dmitrij Frishman, et al.
RNA (New York, N.Y.)|March 29, 2011
miTALOS: analyzing the tissue-specific regulation of signaling pathways by human and mouse microRNAsAndreas Kowarsch, Martin Preusse, Carsten Marr, et al.
Plos One|July 9, 2010
Tissue-specific target analysis of disease-associated microRNAs in human signaling pathwaysAndreas Kowarsch, Carsten Marr, Daniel Schmidl, et al.
BMC Bioinformatics|December 2, 2010
Knowledge-based matrix factorization temporally resolves the cellular responses to IL-6 stimulationAndreas Kowarsch, Florian Blöchl, Sebastian Bohl, et al.
Haematologica|August 30, 2012
High frequencies of SF3B1 and JAK2 mutations in refractory anemia with ring sideroblasts associated with marked thrombocytosis strengthen the assignment to the category of myelodysplastic/myeloproliferative neoplasmsSabine Jeromin, Torsten Haferlach, Vera Grossmann, et al.
Genome Biology|January 22, 2010
PhenomiR: a knowledgebase for microRNA expression in diseases and biological processesAndreas Ruepp, Andreas Kowarsch, Daniel Schmidl, et al.
Blood|March 24, 2012
Multilineage dysplasia does not influence prognosis in CEBPA-mutated AML, supporting the WHO proposal to classify these patients as a unique entityUlrike Bacher, Susanne Schnittger, Katja Macijewski, et al.
BMC Systems Biology|August 27, 2011
MicroRNAs coordinately regulate protein complexesSteffen Sass, Sabine Dietmann, Ulrike C Burk, et al.
Haematologica|June 27, 2012
Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders: an analysis of 636 casesSusanne Schnittger, Ulrike Bacher, Tamara Alpermann, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|December 7, 2011
PhenomiR: microRNAs in human diseases and biological processesAndreas Ruepp, Andreas Kowarsch, Fabian Theis
Plos Computational Biology|September 24, 2010
Correlated mutations: a hallmark of phenotypic amino acid substitutionsAndreas Kowarsch, Angelika Fuchs, Dmitrij Frishman, et al.
RNA (New York, N.Y.)|March 29, 2011
miTALOS: analyzing the tissue-specific regulation of signaling pathways by human and mouse microRNAsAndreas Kowarsch, Martin Preusse, Carsten Marr, et al.
Plos One|July 9, 2010
Tissue-specific target analysis of disease-associated microRNAs in human signaling pathwaysAndreas Kowarsch, Carsten Marr, Daniel Schmidl, et al.
BMC Bioinformatics|December 2, 2010
Knowledge-based matrix factorization temporally resolves the cellular responses to IL-6 stimulationAndreas Kowarsch, Florian Blöchl, Sebastian Bohl, et al.
Haematologica|August 30, 2012
High frequencies of SF3B1 and JAK2 mutations in refractory anemia with ring sideroblasts associated with marked thrombocytosis strengthen the assignment to the category of myelodysplastic/myeloproliferative neoplasmsSabine Jeromin, Torsten Haferlach, Vera Grossmann, et al.
Genome Biology|January 22, 2010
PhenomiR: a knowledgebase for microRNA expression in diseases and biological processesAndreas Ruepp, Andreas Kowarsch, Daniel Schmidl, et al.
Blood|March 24, 2012
Multilineage dysplasia does not influence prognosis in CEBPA-mutated AML, supporting the WHO proposal to classify these patients as a unique entityUlrike Bacher, Susanne Schnittger, Katja Macijewski, et al.
BMC Systems Biology|August 27, 2011
MicroRNAs coordinately regulate protein complexesSteffen Sass, Sabine Dietmann, Ulrike C Burk, et al.
Haematologica|June 27, 2012
Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders: an analysis of 636 casesSusanne Schnittger, Ulrike Bacher, Tamara Alpermann, et al.
Pageof 2